Barclays
VIVE

Barclays’s VIVEVE MED INC VIVE Stock Holding History

Barclays’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-269
Closed – – 5423
2022
Q1 		$0 Buy
+269
New +$269 ﹤0.01% 5791
2019
Q3 		– Sell
-2
Closed -$1K – 7290
2019
Q2 		$1K Hold
2
– – ﹤0.01% 6870
2019
Q1 		$2K Hold
2
– – ﹤0.01% 6880
2018
Q4 		$2K Hold
2
– – ﹤0.01% 6754
2018
Q3 		$7K Sell
2
-24
-92% -$68K ﹤0.01% 6738
2018
Q2 		$71K Buy
26
+22
+550% +$63.4K ﹤0.01% 5457
2018
Q1 		$16K Buy
4
+1
+33% +$4.35K ﹤0.01% 6513
2017
Q4 		$14K Buy
+3
New +$15.6K ﹤0.01% 6430
2017
Q3 		– Hold
0
– – – 6620
2017
Q2 		– Hold
0
– – – 6458

Other funds holding VIVE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return